What don’t you like about it?
In a different universe Race would have a few hundred million dollars in the bank and could develop a companion diagnostic before knowing if bisantrene will affect m6A levels in patients, but we don’t live in that universe.
The positive news is the work we have done to date will really help speed up the development timeline if we do need a companion diagnostic.
Pillar 1 - FTO (new thread), page-2877
- There are more pages in this discussion • 52 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.79 |
Change
0.035(2.00%) |
Mkt cap ! $303.9M | |||
| Open | High | Low | Value | Volume |
| $1.79 | $1.79 | $1.70 | $916.8K | 527.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 910 | $1.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.79 | 9427 | 1 |
View Market Depth
| Last trade - 16.10pm 10/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.75 |
Change
0.035 ( 0.75 %) |
||||
| Open | High | Low | Volume | ||
| $1.76 | $1.77 | $1.70 | 30396 | ||
| Last updated 15.57pm 10/06/2024 ? | |||||
| RAC (ASX) Chart |